Pursuant to § 56 (2) of the Austrian Medicines Act (AMG), as amended, and § 26 of the Austrian Veterinary Medicines Act (TAMG), as amended, the marketing authorisation holder (MAH) or holder of a registration is obliged to report an information officer to the Federal Office for Safety in Health Care (BASG).
The appointment of information officers and any changes thereto must be reported to the BASG without delay.